Bénedith Oben

Ms. Bénedith Oben


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Clinical Lymphoma Myeloma and Leukemia
Verified
Journal Article
Closed access
Charlotte CosemansCharlotte Cosemans
Charlotte Cosemans
BOBénedith Oben
Bénedith Oben
IAIngrid Arijs
Ingrid Arijs
ADAnnick Daniëls
Annick Daniëls
JDJeroen Declercq
Jeroen Declercq
JRJean-Luc Rummens
Jean-Luc Rummens

12 August 2019 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
BOBénedith Oben
Bénedith Oben
Charlotte CosemansCharlotte Cosemans
Charlotte Cosemans
IAIngrid Arijs
Ingrid Arijs
LLLoes Linsen
Loes Linsen
ADAnnick Daniëls
Annick Daniëls
JRJean-Luc Rummens
Jean-Luc Rummens
Biobanking is increasingly important in studying complex heterogeneous diseases. Therefore, it is essential to ensure the sample quality after long-term storage for reliable downstream analyses. The Clinical Biobank of the Jessa Hospital and the University Biobank Limburg (UBiLim) hold a continuously growing collection of hematological samples, including May-Grünwald–Giemsa (MGG)- and Perls' Prussian Blue (PPB)-stained bone marrow (BM) smears, stored at room temperature (RT) for up to 20 years. In this study, we investigated the effect of short- and long-term storage on the quality of DNA and RNA extracted from these BM smears to assess their fitness-for-purpose in downstream molecular applications, including agarose gel electrophoresis, bio-analyzer analysis, quantitative polymerase chain reaction (qPCR), and targeted next-generation sequencing (NGS). The RNA quality was very low for all samples, independent of storage time or staining method. The DNA from PPB-stained BM smears was already degraded after 1 year of storage and correspondingly could not be used for reliable downstream molecular analysis. In contrast, DNA extracted from MGG-stained BM smears stored for up to 10 years was able to generate high-quality data in qPCR and targeted NGS analyses. Longer storage periods (>15 years) of these samples revealed a high degree of degradation and a significant amount of DNA transitions and transversions. In conclusion, the DNA extracted from archival MGG-stained BM smears with a storage time up to at least 10 years was qualitatively good and fit for downstream analysis, including targeted NGS. This indicates that these samples are an eligible source for molecular DNA research and for studying complex diseases.

18 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
BOBénedith Oben
Bénedith Oben
Charlotte CosemansCharlotte Cosemans
Charlotte Cosemans
EGEllen Geerdens
Ellen Geerdens
LLLoes Linsen
Loes Linsen
KVKimberly Vanhees
Kimberly Vanhees
JRJean-Luc Rummens
Jean-Luc Rummens
Multiple myeloma (MM), or Kahler’s disease, is an incurable plasma cell (PC) cancer in the bone marrow (BM). This malignancy is preceded by one or more asymptomatic precursor conditions, monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering multiple myeloma (SMM). The molecular mechanisms and exact cause of this progression are still not completely understood. In this study, the mutational profile underlying the progression from low–intermediate risk myeloma precursor conditions to MM was studied in serial BM smears. A custom capture-based sequencing platform was developed, including 81 myeloma-related genes. The clonal evolution of single nucleotide variants and short insertions and deletions was studied in serial BM smears from 21 progressed precursor patients with a median time of progression of six years. From the 21 patients, four patients had no variation in one of the 81 studied genes. Interestingly, in 16 of the 17 other patients, at least one variant present in MM was also detected in its precursor BM, even years before progression. Here, the variants were present in the pre-stage at a median of 62 months before progression to MM. Studying these paired BM samples contributes to the knowledge of the evolutionary genetic landscape and provides additional insight into the mutational behavior of mutant clones over time throughout progression.